| Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial |
16 |
| The nature, consequences, and management of neurological disorders in chronic kidney disease |
15 |
| Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study |
11 |
| Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial |
7 |
| Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys (R) vascular access system |
7 |
| Predictors of post-hospitalization recovery of renal function among patients with acute kidney injury requiring dialysis |
6 |
| The effect of a hemodialysis patient education program on fluid control and dietary compliance |
6 |
| Effects of weight-based ultrafiltration rate limits on intradialytic hypotension in hemodialysis |
6 |
| Management of pain in end-stage renal disease patients: Short review |
6 |
| Effects of acute intradialytic exercise on cardiovascular responses in hemodialysis patients |
5 |
| Coronal mode ultrasound guided hemodialysis cannulation: A pilot randomized comparison with standard cannulation technique |
5 |
| Sertraline can reduce uremic pruritus in hemodialysis patient: A double blind randomized clinical trial from Southern Iran |
5 |
| Depressive symptoms, frailty, and mortality among dialysis patients |
5 |
| The relationship between serum magnesium levels and mortality in non-diabetic hemodialysis patients: A 10-year follow-up study |
5 |
| Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection in end stage renal disease patients: A prospective observational study |
5 |
| Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration |
5 |
| Salvage of exhausted neck access using a novel inside-out device in dialysis-dependent patients |
5 |
| Factors affecting the patency of arteriovenous fistulas for hemodialysis: Single center experience |
5 |
| Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort |
4 |
| Biomarkers upon discontinuation of renal replacement therapy predict 60-day survival and renal recovery in critically ill patients with acute kidney injury |
4 |
| Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience |
4 |
| Efficacy and safety of low-dose heparin in hemodialysis |
4 |
| Assessment of intradialysis calcium mass balance by a single pool variable-volume calcium kinetic model |
4 |
| Continuous renal replacement therapy is associated with acute cardiac stunning in critically ill patients |
4 |
| Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients |
4 |
| Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients |
4 |
| Comparison between clinical judgment and integrated lung and inferior vena cava ultrasonography for dry weight estimation in hemodialysis patients |
4 |
| Development of a risk-prediction model for Middle East respiratory syndrome coronavirus infection in dialysis patients |
4 |
| Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies |
4 |
| The home hemodialysis patient experience: A qualitative assessment of modality use and discontinuation |
3 |
| Why does the choice of dialysate sodium concentration remain controversial? |
3 |
| Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients |
3 |
| Impact of salt reduction in meals consumed during hemodialysis sessions on interdialytic weight gain and hemodynamic stability |
3 |
| Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis |
3 |
| The prevention of hepatitis C virus transmission to hemodialysis patients and staff members |
3 |
| Left ventricular geometric patterns in end-stage kidney disease: Determinants and course over time |
3 |
| Effect of incident nocturnal home hemodialysis versus incident continuous ambulatory peritoneal dialysis on employment rate, clinical, and laboratory outcomes: A 1-year retrospective observation study |
3 |
| Feasibility of sustained low efficiency dialysis in critically sick pediatric patients: A multicentric retrospective study |
3 |
| Comparison of stroke volume measurements during hemodialysis using bioimpedance cardiography and echocardiography |
3 |
| Comparison of biocompatibility in polysulfone dialysis membranes with different sterilization |
3 |
| Choosing a dialyzer: What clinicians need to know |
3 |
| Brain white matter microstructure in end-stage kidney disease, cognitive impairment, and circulatory stress |
3 |
| Association between afebrile status and in-hospital mortality among adult chronic hemodialysis patients with bacteremia |
3 |
| Gender disparity in fistula use at initiation of hemodialysis varies markedly across ESRD networksAnalysis of USRDS data |
3 |
| Dermatologic manifestations in end stage renal disease |
2 |
| Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis |
2 |
| High variability of teicoplanin concentration in patients with continuous venovenous hemodiafiltration |
2 |
| Survival comparisons of intensive vs. conventional hemodialysis: Pitfalls and lessons |
2 |
| Impact of arteriovenous fistula cannulation on the quality of dialysis |
2 |
| The association of the ankle-brachial index, the toe-brachial index, and their difference, with mortality and limb outcomes in dialysis patients |
2 |
